Skip to main content
Signal8

McClellan Mark B.

SEC insider (Form 3/4/5 filer). CIK 0001567006. Director at JOHNSON & JOHNSON (JNJ) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 23, 2026. Located in BLOOMFIELD, CT.

Companies McClellan Mark B. has filed insider reports for

  • JOHNSON & JOHNSON (JNJ): Director
  • Cigna Group (CI): Director
  • Alignment Healthcare, Inc. (ALHC): Director
McClellan Mark B. profile photo

McClellan Mark B.

CIK: 0001567006

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

JOHNSON & JOHNSON logo
JNJ

JOHNSON & JOHNSON

Director
Cigna Group logo
CI

Cigna Group

Director
Alignment Healthcare, Inc. logo
ALHC

Alignment Healthcare, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • JOHNSON & JOHNSON logo
    JNJ

    JOHNSON & JOHNSON

    Apr 23, 2026
    Award

    Deferred Share Units

    Direct
    975 shares-
  • Cigna Group logo
    CI

    Cigna Group

    Apr 22, 2026
    Award
    Direct
    782 shares-
  • Alignment Healthcare, Inc. logo
    ALHC

    Alignment Healthcare, Inc.

    Mar 13, 2026
    Award
    Direct
    13.1K shares-
  • JOHNSON & JOHNSON logo
    JNJ

    JOHNSON & JOHNSON

    Apr 24, 2025
    Award

    Deferred Share Units

    Direct
    1.3K shares-
  • Cigna Group logo
    CI

    Cigna Group

    Apr 23, 2025
    Award
    Direct
    638 shares-
  • Alignment Healthcare, Inc. logo
    ALHC

    Alignment Healthcare, Inc.

    Mar 13, 2025
    Award
    Direct
    12.3K shares-

1-6 of 6